Part 6: Electrolyte Disorders

22: Hypokalemia

 

Chapter outlines

POTASSIUM
Physiological Basis
Potassium Homeostasis
Regulation of Serum Potassium
Correlation of Serum and Body Potassium
HYPOKALEMIA
Etiology
Clinical Features and ECG Changes
Diagnosis
History and physical examination
Laboratory evaluation
Additional diagnostic tests
- Urinary potassium excretion
- Acid-base status
Management
Goals
Prevention
Replenishment of potassium deficit
- Estimation of the potassium deficit
- Selection of treatment modality
- Precautions
- How much and how long
Oral potassium supplementation
Intravenous potassium supplementation
- Selection of formulations
- Potassium containing IV fluids
- Indications
- Recommendations for administration
- Special considerations
The target of K+ supplementation
Correction of the underlying causes

POTASSIUM

PHYSIOLOGICAL BASIS

Potassium (K+) is a major intracellular cation and the second most abundant cation in the body (next to cation sodium). Total body potassium is about 3,500 mEq. Out of this, 98% of potassium is intracellular, and just 2% of potassium is extracellular. Thus, the normal serum potassium concentration is 3.5 to 5.0 mEq/L vs. an intracellular 140 to 150 mEq/L.
Potassium plays a crucial role in the following:
  • Normal functioning of cells: Synthesis of DNA and protein, cell division and growth, enzyme function.
  • Neuromuscular transmission: Maintaining cell membrane potential, cellular excitability, conduction of nerve impulses which help in maintaining skeletal, cardiac, and smooth muscle cell contraction.
  • Regulate intracellular osmolality and cell volume.
  • Maintain acid-base balance and regulate intracellular pH.

POTASSIUM HOMEOSTASIS

The average potassium intake is about 77 and 59 mEq per day in adult men and women, respectively [1]. 90% of potassium consumed is absorbed in the upper gastrointestinal (GI) tract, out of which kidneys excrete 90%, and the remaining 10% is excreted in the stool.

REFERENCES

  1. U.S. Department of Agriculture, Agricultural Research Service. What We Eat in America, 2013–2014.
  2. Rastegar A. Serum Potassium. In: Walker HK, Hall WD, Hurst JW, editors. Clinical Methods: The History, Physical, and Laboratory Examinations. 3rd edition. Boston: Butterworths; 1990. Chapter 195. Available from: https://www.ncbi.nlm.nih.gov/books/NBK307/.
  3. Palmer BF. Regulation of potassium homeostasis. Clinical Journal of the American Society of Nephrology 2015;10(6):1050–1060.
  4. Gumz ML, Rabinowitz L, Wingo CS. An Integrated View of Potassium Homeostasis. N Engl J Med. 2015;373(1):60–72.
  5. Kardalas E, Paschou SA, Anagnostis P, et al. Hypokalemia: a clinical update. Endocr Connect. 2018;7(4):R135–R146.
  6. Palmer BF, Clegg DJ. Physiology and Pathophysiology of Potassium Homeostasis: Core Curriculum 2019. Am J Kidney Dis. 2019;74(5):682–695.
  7. Marti G, Schwarz C, Leichtle AB, et al. Etiology and symptoms of severe hypokalaemia in emergency department patients. European Journal of Emergency Medicine 2014;21(1):46–51.
  8. Viera AJ, Wouk N. Potassium Disorders: Hypokalemia and Hyperkalemia. Am Fam Physician. 2015;92(6):487–95.
  9. Aronson PS, Giebisch G. Effects of pH on potassium: new explanations for old observations. J Am Soc Nephrol. 2011;22(11):1981–1989.
  10. Huang CL, Kuo E. Mechanism of hypokalemia in magnesium deficiency. J Am Soc Nephrol. 2007;18(10):2649–52.
  11. Yalamanchili HB, Calp-Inal S, Zhou XJ, et al. Hypokalemic Nephropathy. Kidney Int Rep. 2018;3(6):1482–1488.
  12. Levis JT. ECG diagnosis: hypokalemia. Perm J. 2012;16(2):57.
  13. Kishimoto C, Tamaru K, Kuwahara H. Tall P waves associated with severe hypokalemia and combined electrolyte depletion. J Electrocardiol. 2014;47(1):93–4.
  14. Wang X, Han D, Li G. Electrocardiographic manifestations in severe hypokalemia. J Int Med Res. 2020;48(1):300060518811058.
  15. Krogager ML, Kragholm K, Thomassen JQ, et al. Update on management of hypokalaemia and goals for the lower potassium level in patients with cardiovascular disease: a review in collaboration with the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy, European Heart Journal - Cardiovascular Pharmacotherapy, 2021;pvab038.
  16. Groeneveld JH, Sijpkens YW, Lin SH, et al. An approach to the patient with severe hypokalaemia: the potassium quiz. QJM. 2005;98(4):305–16.
  17. Abcar AC, Kujubu DA. Evaluation of hypertension with hypokalemia. Perm J. 2009;13(1):73–76.
  18. Jędrusik P, Symonides B, Wojciechowska E, et al. Diagnostic value of potassium level in a spot urine sample as an index of 24-hour urinary potassium excretion in unselected patients hospitalized in a hypertension unit. PLoS One. 2017;12(6):e0180117.
  19. Palmer BF, Clegg DJ. The Use of Selected Urine Chemistries in the Diagnosis of Kidney Disorders. Clin J Am Soc Nephrol. 2019;14(2):306–316.
  20. Grams ME, Hoenig MP, Hoorn EJ. Evaluation of Hypokalemia. JAMA. 2021;325(12):1216–1217.
  21. Kamel K, Halperin M. Intrarenal urea recycling leads to a higher rate of renal excretion of potassium: an hypothesis with clinical implications. Curr Opin Nephrol Hypertens 2011;20(5):547–54.
  22. Halperin ML. Assessing the renal response in patients with potassium disorders: a shift in emphasis from the TTKG to the urine K+/creatinine ratio. Afr J Nephrol. 2017;20(1):22–24.
  23. Bourke E, Delaney V. Prevention of hypokalemia caused by diuretics. Heart Dis Stroke. 1994;3(2):63–7.
  24. Cohn JN, Kowey PR, Whelton PK, et al. New Guidelines for Potassium Replacement in Clinical Practice: A Contemporary Review by the National Council on Potassium in Clinical Practice. Arch Intern Med. 2000;160(16):2429–2436.
  25. Scotto CJ, Fridline M, Menhart CJ, Klions HA. Preventing hypokalemia in critically ill patients. Am J Crit Care. 2014;23(2):145–9.
  26. Gennari FJ. Hypokalemia. N Engl J Med 1998;339(7):451–458.
  27. Asmar A, Mohandas R, Wingo CS. A physiologic-based approach to the treatment of a patient with hypokalemia. Am J Kidney Dis. 2012;60(3):492–7.
  28. Farkas J. Hypokalemia. Internet Book of Critical Care (IBCC) June 25, 2021. Visit: https://emcrit.org/ibcc/hypokalemia/.
  29. Pasquel FJ, Tsegka K, Wang H, et al. Clinical outcomes in patients with isolated or combined diabetic ketoacidosis and hyperosmolar hyperglycemic state: a retrospective, hospital-based cohort study. Diabetes Care 2020;43(3):349–57.
  30. Umpierrez GE, Murphy MB, Kitabchi AE. Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar Syndrome. Diabetes Spectrum 2002;15(1):28–36.
  31. Kitabchi AE, Umpierrez GE, Miles JM, et al. Hyperglycemic crises in adult patients with diabetes. Diabetes Care 2009;32(7):1335–1343.
  32. Adrogué HJ, Lederer ED, Suki WN, Eknoyan G. Determinants of plasma potassium levels in diabetic ketoacidosis. Medicine (Baltimore) 1986;65(3):163–172.
  33. Pasquel FJ, Lansang MC, Dhatariya K, et al. Management of diabetes and hyperglycaemia in the hospital. Lancet Diabetes Endocrinol. 2021;9(3):174–188.
  34. Clase CM, Carrero JJ, Ellison DH, et al; Conference Participants. Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2020;97(1):42–61.
  35. Wainwright NJ, Azim A, Neary JD. Proton Pump Inhibition in the Management of Hypokalemia in Anorexia Nervosa with Self-Induced Vomiting. Canadian Journal of General Internal Medicine 2018;13(3):35–38.
  36. Tella SH, Kommalapati A. Thyrotoxic Periodic Paralysis: An Underdiagnosed and Under-recognized Condition. Cureus. 2015;7(10):e342.
TABLE OF CONTENTS